Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naive Patients in the Caribbean and Central and South America

Caro-Vega, Y; Belaunzaran-Zamudio, PF; Crabtree-Ramirez, BE; Shepherd, BE; Grinsztejn, B; Wolff, M; Pape, JW; Padgett, D; Gotuzzo, E; McGowan, CC; Sierra-Madero, JG

Keywords: latin america, hiv, antiretroviral therapy, protease inhibitor, durability, nonnucleoside reverse transcriptase inhibitor

Más información

Título según WOS: Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naive Patients in the Caribbean and Central and South America
Título según SCOPUS: Durability of efavirenz compared with boosted protease inhibitor-based regimens in antiretroviral-naïve patients in the Caribbean and central and South America
Título de la Revista: OPEN FORUM INFECTIOUS DISEASES
Volumen: 5
Número: 3
Editorial: OXFORD UNIV PRESS INC
Fecha de publicación: 2018
Idioma: English
DOI:

10.1093/ofid/ofy004

Notas: ISI, SCOPUS